Ergoteles LLC Sutro Biopharma, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $49,682 - $68,737	11,690 New	11,690 $54,000
Q2 2022 Aug 12, 2022	BUY	$3.41 - $8.95 $199,727 - $524,210	58,571 Added 227.57%	84,309 $439,000
Q1 2022 May 13, 2022	BUY	$7.78 - $15.31 $75,644 - $148,859	9,723 Added 60.71%	25,738 $212,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $228,213 - $376,832	16,015 New	16,015 $238,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.